Back to search

Article

Methionine synthase polymorphism is a risk factor for Alzheimer disease

2003-07-01

Abstract excerpt

Alzheimer disease (AD) patients show increased plasma levels of homocysteine, whose conversion to methionine is catalyzed by methionine synthase (MS). Although altered MS activity may result from the MS A2756G polymorphism, the latter's possible association with AD remains unexplored. To assess whether the MS A2756G polymorphism holds any influence on AD risk, we have analyzed 172 AD patients and 166 controls. We...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
85c0048f-3cbd-56f1-923a-eef041463423
DOI
10.1097/00001756-200307180-00022
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Methionine synthase polymorphism is a risk factor for Alzheimer diseaseDOI 10.1097/00001756-200307180-00022
Select a neighboring publication to make it the new centre.